Inabata (8098) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
8 Jun, 2026Business performance and strengths
Achieved record-high operating profit for six consecutive years, with FY03/26 net sales at ¥832.7 billion and operating profit at ¥26.1 billion.
Built a client base of about 10,000 companies over 130+ years, specializing in chemicals with nearly 70 overseas bases in 19 countries.
Solid business foundation in Asia, with 60 bases in 12 countries and 60% of consolidated personnel located there.
Medium-term management plan and financial targets
NC2026 targets for FY03/27: net sales ¥950 billion, operating profit ¥27 billion, ROE 10%+, and net debt/equity ratio ≤0.5.
Profits in FY03/26 exceeded projections, with ordinary profit and profit attributable to owners surpassing final-year targets.
Segment performance: Chemicals and Plastics met targets; Life Industry improved; Information & Electronics faced a challenging environment.
Capital allocation and investments
Allocated ¥46.2 billion to growth investments and shareholder returns through the second year of NC2026.
Major investments included M&A (Novacel, Daigo Tsusho, Satoen), biomass power, automotive materials, and food-related businesses.
M&A projects are contributing steadily to earnings, with anticipated synergies in plastics and food businesses.
Latest events from Inabata
- Record profits driven by Chemicals and Life Industry; dividend policy and payout enhanced.8098
Q4 202611 May 2026 - Record sales and profit growth, raised forecasts, and key acquisitions drive the period.8098
Q2 202520 Mar 2026 - Record sales and profit growth, but net profit fell due to absence of prior one-time gain.8098
Q1 202520 Mar 2026 - Strong sales and profit growth, stable outlook, and key acquisitions drive performance.8098
Q3 202520 Mar 2026 - Record sales and profit growth, led by Plastics and Electronics, with robust shareholder returns.8098
Q4 202520 Mar 2026 - Record ordinary profit achieved despite lower sales and mixed segment results.8098
Q1 202620 Mar 2026 - Record profits achieved despite lower sales, with dividends rising for the eighth year.8098
Q2 202620 Mar 2026 - Record ordinary profit and strong segment growth offset declines in sales and profit.8098
Q3 202620 Mar 2026